| Politicians, regulatory authorities, and collaboration with industry. | 內分泌
> 生長障礙 | 監管合作關係
> 與監管機構合作 | 1,000 | National | Regularly | 119027172028 |
| We are represented on the patient council of the NT/MTP-rådet [rådet för nya terapier/medicintekniska produkter – New Therapies/Medical Technology Products Council]. | 內分泌
> 甲狀腺疾病 | 監管合作關係
> 與監管機構合作 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 思覺失調症 | 監管合作關係
> 與監管機構合作 | 5,000 | National | Regularly | 119054525537 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen), and serve on working groups for various national clinical guidelines, among other activities. | 風濕性
> 風濕性疾病：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Regularly | 119012976039 |
| We participate in TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] assessments relating to bleeding disorders. | 出血
> 出血性疾病：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100 | National | Regularly | 119013112468 |
| Meetings with companies prior to reimbursement applications. | 內分泌
> 生長障礙 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Regularly | 119027170967 |
| Meetings with companies prior to reimbursement applications. Meetings with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] to improve the process at a national level. Meetings with policymakers for the same purpose. | 內分泌
> 生長障礙 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Regularly | 119027170967 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency]. | 心理健康
> 思覺失調症 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Sometimes | 119035155217 |
| We participate in the patient council of the NT/MTP Council [NT-rådet (Rådet för nya terapier)/MTP-rådet (Medicintekniska produktrådet) - the Swedish national body issuing recommendations on new therapies and medicinal products]. In individual cases, we have been in contact with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] ahead of pricing decisions for medicines. | 內分泌
> 甲狀腺疾病 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 思覺失調症 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 5,000 | National | Regularly | 119054525537 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], for example. | 巨蟹座
> 癌症：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Regularly | 119054604148 |
| EMA [European Medicines Agency]. | 肝臟
> 肝炎 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | National | Regularly | 119036786869 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen - looking at municipal versus national healthcare responsbilities), and serve on working groups for various national clinical guidelines, among other activities. | 風濕性
> 風濕性疾病：大多數類型 | 監管合作關係
> 參與臨床指引制定機構 | 100,000 | National | Regularly | 119012976039 |
| Collaboration with the medicines committee. | 骨骼
> 骨質疏鬆症 | 監管合作關係
> 參與臨床指引制定機構 | 10,000 | National | Sometimes | 119012989318 |
| We have participated in the development of national clinical guidelines. | 神經系統
> 偏頭痛 | 監管合作關係
> 參與臨床指引制定機構 | 100 | National | Sometimes | 119021956027 |
| Politicians, regulatory authorities, and collaboration with industry. | 內分泌
> 生長障礙 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 1,000 | National | Regularly | 119027172028 |
| Through EAPN [European Anti-Poverty Network] in the Riksdag [Swedish Parliament]. | 心理健康
> 心理健康：大多數狀況 | 監管合作關係
> 與其他醫療倡導者 | 1,000 | Local | Rarely | 119012977988 |
| Meetings with companies prior to reimbursement applications. Meetings with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] to improve the process at a national level. Meetings with policymakers for the same purpose. | 內分泌
> 生長障礙 | 影響政策與立法
> 影響醫療保健政策與法規 | 1,000 | National | Regularly | 119027170967 |
| Primarily in political contexts, through advisory councils and similar bodies, in response to political indifference. | 心理健康
> 心理健康：大多數狀況 | 影響政策與立法
> 影響醫療保健政策與法規 | 100 | Local | Regularly | 119054580960 |
| We have met with regional politicians and provided information about the disease. | 巨蟹座
> 癌症：攝護腺 | 影響政策與立法
> 動員國會議員與政治領袖 | 1,000 | Regional | Sometimes | 119014676970 |
| We participate in the patient council of the NT/MTP Council [NT-rådet (Rådet för nya terapier)/MTP-rådet (Medicintekniska produktrådet) - the Swedish national body issuing recommendations on new therapies and medicinal products]. In individual cases, we have been in contact with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] ahead of pricing decisions for medicines. | 內分泌
> 甲狀腺疾病 | 定價與可負擔性倡議
> 參與價格審查委員會談判 | 100,000 | National | Sometimes | 119035997555 |
| We have previously been involved when a specific dressing was replaced with something “equivalent.” If contacting the hospital does not help, we have sometimes taken it further with the support of the company whose dressing we are trying to obtain. | 稀有
> 罕見疾病：EB | 定價與可負擔性倡議
> 監控產品替代 | 1,000 | National | Rarely | 119062893384 |
| We have previously been involved when a specific dressing was replaced with something “equivalent.” If contacting the hospital does not help, we have sometimes taken it further with the support of the company whose dressing we are trying to obtain. | 稀有
> 罕見疾病：EB | 診斷與藥品配送
> 確保藥物使用的安全性與有效性 | 1,000 | National | Rarely | 119062893384 |
| We have participated in the development of national clinical guidelines. | 神經系統
> 偏頭痛 | 診斷與藥品配送
> 參與臨床指引的制定 | 100 | National | Sometimes | 119021956027 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen), and serve on working groups for various national clinical guidelines, among other activities. | 風濕性
> 風濕性疾病：大多數類型 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 100,000 | National | Regularly | 119012976039 |
| We have a dedicated advocacy representative who monitors developments and safeguards our interests. | 心理健康
> 心理健康：大多數狀況 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 100 | Local | Rarely | 119022071652 |
| We are represented on the patient council of the NT/MTP-rådet [rådet för nya terapier/medicintekniska produkter – New Therapies/Medical Technology Products Council]. | 內分泌
> 甲狀腺疾病 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 思覺失調症 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 5,000 | National | Regularly | 119054525537 |
| Primarily in political contexts, through advisory councils and similar bodies, in response to political indifference. | 心理健康
> 心理健康：大多數狀況 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 100 | Local | Regularly | 119054580960 |
互動
行動與倡議
16 提及
